Bullishcharts

$SRPT Sarpeta Monday Trade

Long
NASDAQ:SRPT   Sarepta Therapeutics, Inc.
Entry level $132.59 = Target price $138.82 = Stop loss $130.66
7&12 MA's cross imminent.
Sarepta Therapeutics could very well continue to surge on the FDA approval.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.